Skip to main content

Heron Therapeutics, Inc.

HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000818033

No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Heron Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
161
+10 vs. Q4 2023
Shares held
119.4M
+6.90M (+6.1%) vs. Q4 2023
Total value
$330.5M
+$139.3M (+72.9%) vs. Q4 2023
New holders
28
46 more added
Sold out
18
46 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 161 institutions
Q1 2021: 193 institutionsQ2 2021: 189 institutionsQ3 2021: 197 institutionsQ4 2021: 200 institutionsQ1 2022: 186 institutionsQ2 2022: 174 institutionsQ3 2022: 186 institutionsQ4 2022: 176 institutionsQ1 2023: 162 institutionsQ2 2023: 149 institutionsQ3 2023: 141 institutionsQ4 2023: 151 institutionsQ1 2024: 161 institutionsQ2 2024: 190 institutionsQ3 2024: 173 institutionsQ4 2024: 161 institutionsQ1 2025: 165 institutionsQ2 2025: 171 institutionsQ3 2025: 172 institutionsQ4 2025: 170 institutionsQ1 2026: 167 institutionsQ2 2026: 163 institutions
Value heldQ1 2024: $330.5M
Q1 2021: $1.48BQ2 2021: $1.61BQ3 2021: $1.16BQ4 2021: $1.07BQ1 2022: $620.5MQ2 2022: $321.6MQ3 2022: $514.2MQ4 2022: $289.5MQ1 2023: $163.1MQ2 2023: $114.7MQ3 2023: $121.9MQ4 2023: $191.2MQ1 2024: $330.5MQ2 2024: $453.7MQ3 2024: $242.4MQ4 2024: $175.8MQ1 2025: $274.5MQ2 2025: $272.1MQ3 2025: $192.4MQ4 2025: $203.2MQ1 2026: $125.6MQ2 2026: $57.1M
Institutions holding HRTX and their total value by quarter
QuarterHoldersValue
Q2 2026163$57.1M
Q1 2026167$125.6M
Q4 2025170$203.2M
Q3 2025172$192.4M
Q2 2025171$272.1M
Q1 2025165$274.5M
Q4 2024161$175.8M
Q3 2024173$242.4M
Q2 2024190$453.7M
Q1 2024161$330.5M
Q4 2023151$191.2M
Q3 2023141$121.9M
Q2 2023149$114.7M
Q1 2023162$163.1M
Q4 2022176$289.5M
Q3 2022186$514.2M
Q2 2022174$321.6M
Q1 2022186$620.5M
Q4 2021200$1.07B
Q3 2021197$1.16B
Q2 2021189$1.61B
Q1 2021193$1.48B

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding HRTX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Capital Planning Advisors, LLC63,820$176.8K0.03%+24,150+60.9%Added
Quinn Opportunity Partners LLC72,097$199.7K0.02%00.0%Unchanged
Engineers Gate Manager LP75,138$208.1K0.01%+6,719+9.8%Added
Squarepoint Ops LLC77,540$214.8K0.00%+77,540New
Motiv8 Investments LLC77,717$215.3K0.17%−140.0%Reduced
Two Sigma Investments, LP80,564$223.2K0.00%+80,564New
Searle & Co.86,250$238.9K0.06%+1,000+1.2%Added
Raymond James & Associates87,520$242.4K0.00%+87,520New
UBS Group AG111,394$308.6K0.00%−10,082−8.3%Reduced
Apeiron RIA LLC124,000$343.5K0.10%+41,000+49.4%Added
Barclays PLC136,459$378.0K0.00%−42,295−23.7%Reduced
Rhumbline Advisers140,242$388.5K0.00%+4,445+3.3%Added
Alliancebernstein L.P.165,030$457.1K0.00%−28,590−14.8%Reduced
D.A. Davidson & Co.171,000$473.7K0.00%+140,900+468.1%Added
Susquehanna International Group, LLP185,898$514.9K0.00%+116,673+168.5%Added
Morgan Stanley198,999$551.2K0.00%−263,149−56.9%Reduced
XTX Topco Ltd208,787$578.3K0.08%+104,513+100.2%Added
Bank of America Corp235,042$651.1K0.00%+48,564+26.0%Added
Jane Street Group, LLC268,463$743.6K0.00%+101,867+61.1%Added
EAM Investors, LLC274,510$760.4K0.12%+274,510New
Gsa Capital Partners LLP279,699$775.0K0.06%−59,749−17.6%Reduced
KBC Group NV289,269$801.0K0.00%00.0%Unchanged
Richmond Brothers, Inc.296,706$821.9K1.52%00.0%Unchanged
CM Management, LLC300,000$831.0K0.70%−25,000−7.7%Reduced
FMR LLC319,943$886.2K0.00%+300+0.1%Added
Zweig-DiMenna Associates LLC320,130$886.8K0.08%00.0%Unchanged
Bank of New York Mellon Corp335,557$929.5K0.00%−68,813−17.0%Reduced
Commonwealth Equity Services, LLC338,526$938.0K0.00%+10,122+3.1%Added
Panagora Asset Management Inc375,426$1.04M0.01%+236,313+169.9%Added
Wellington Management Group LLP417,985$1.16M0.00%+417,985New
Zacks Investment Management436,473$1.21M0.01%+125,044+40.2%Added
Highland Capital Management Fund Advisors, L.P.475,750$1.32M0.20%00.0%Unchanged
Los Angeles Capital Management LLC493,264$1.37M0.00%−21,113−4.1%Reduced
Marshall Wace, LLP494,354$1.37M0.00%+494,354New
Qube Research & Technologies Ltd561,984$1.56M0.00%+561,984New
Citadel Advisors LLC573,437$1.59M0.00%+191,658+50.2%Added
Northern Trust Corp959,550$2.66M0.00%−28,541−2.9%Reduced
Charles Schwab Investment Management Inc1,091,138$3.02M0.00%+93,937+9.4%Added
New York State Common Retirement Fund1,094,116$3.03M0.00%−480.0%Reduced
Nuveen Asset Management, LLC1,094,687$3.03M0.00%+1,002,935+1,093.1%Added
Goldman Sachs Group Inc1,400,404$3.88M0.00%+415,753+42.2%Added
Congress Park Capital LLC1,644,785$4.56M2.02%−153,865−8.6%Reduced
Monaco Asset Management SAM1,813,164$5.02M2.23%−413,311−18.6%Reduced
Tang Capital Management LLC1,850,000$5.12M0.53%00.0%Unchanged
Orchard Capital Managment, LLC2,271,883$6.29M1.85%+28,457+1.3%Added
JW Asset Management, LLC2,292,418$6.35M2.32%00.0%Unchanged
Renaissance Technologies LLC2,406,486$6.67M0.01%+523,186+27.8%Added
State Street Corp2,440,870$6.76M0.00%−40,975−1.7%Reduced
D. E. Shaw & Co., Inc.2,695,046$7.47M0.01%+1,404,049+108.8%Added
Clearline Capital LP2,776,204$7.69M0.76%−3,292,350−54.3%Reduced
Geode Capital Management, LLC2,796,119$7.75M0.00%+171,445+6.5%Added
Adage Capital Partners GP, L.L.C.2,910,011$8.06M0.02%00.0%Unchanged
Millennium Management LLC3,167,286$8.77M0.01%+1,930,129+156.0%Added
Palisade Capital Management LLC3,732,241$10.3M0.27%+86,138+2.4%Added
Tejara Capital Ltd4,411,567$12.2M4.53%−863,669−16.4%Reduced
Franklin Resources Inc6,374,584$17.7M0.01%−30,211−0.5%Reduced
Velan Capital Investment Management LP6,986,744$19.4M10.46%00.0%Unchanged
BlackRock Inc.7,286,028$20.2M0.00%+123,676+1.7%Added
Vanguard Group Inc8,114,716$22.5M0.00%−224,196−2.7%Reduced
OrbiMed Advisors LLC10,111,550$28.0M0.55%+4,182,959+70.6%Added
Rubric Capital Management LP26,713,503$74.0M2.19%00.0%Unchanged
HRT Financial LP0$00.00%−199,908−100.0%Sold out
Acadian Asset Management LLC0$00.00%−134,877−100.0%Sold out
Propel Bio Management, LLC0$00.00%−104,195−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−90,000−100.0%Sold out
Captrust Financial Advisors0$00.00%−51,102−100.0%Sold out
Virtu Financial LLC0$00.00%−41,237−100.0%Sold out
X-Square Capital, LLC0$00.00%−31,185−100.0%Sold out
SG Americas Securities, LLC0$00.00%−26,464−100.0%Sold out
Simplex Trading, LLC0$00.00%−20,598−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−20,300−100.0%Sold out
Point72 Middle East FZE0$00.00%−18,500−100.0%Sold out
Estate Counselors, LLC0$00.00%−17,000−100.0%Sold out
National Asset Management, Inc.0$00.00%−11,490−100.0%Sold out
Douglas Lane & Associates, LLC0$00.00%−10,000−100.0%Sold out
Advisory Services Network, LLC0$00.00%−1,479−100.0%Sold out
Raleigh Capital Management Inc.0$00.00%−1,453−100.0%Sold out
ORG Partners LLC0$00.00%−400−100.0%Sold out
National Bank of Canada0$00.00%−100−100.0%Sold out